13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-08-14, with 5 holding rows worth $659,210,000.
- Accession
- 0001104659-14-060602
- Filer
- CIK 1388325
- Filed
- 2014-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2013
A holdings report, 5 entries on the cover page, a total value of $659,210,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $659,209,000 with VALUE read as thousands by filing date, 13F file number 028-16231. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 2,979,100 | $285,755,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 6,910,489 | $223,554,000 | thousands by filing date | |
| Vanguard FTSE Europe ETF | 922042874 | SHS | 2,101,000 | $123,539,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88164N105 | COM | 1,200,000 | $16,224,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 597,359 | $10,137,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-14-060602 | this filing | 2014-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000950123-14-011899 | base | 2014-11-14 | acceptance time not in the bulk data set |